Showing 751-760 of 1403 results for "".
Pompe Disease
https://practicalneurology.com/diseases-diagnoses/child-neurology/pompe-disease/31686/New treatments, available and in development, underscore need for high degree of suspicion for Pompe disease in differential for weakness and respiratory difficulties.Early-Onset Drug-Resistant Epilepsy Due to Gene Variants
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/early-onset-drug-resistant-epilepsy-due-to-gene-variants/31837/Identification of pathogenic gene variants in child-onset drug-resistant epilepsy can be used to guide treatment in children and adults.Stroke Snapshot: Intracerebral Hemorrhage—Surgery and the Future of Clinical Trials
https://practicalneurology.com/columns/stroke/intracerebral-hemorrhage-surgery-and-the-future-of-clinical-trials/35825/By refining patient selection, expanding minimally invasive techniques, and integrating novel therapeutics, the next generation of intracerebral hemorrhage treatment has the potential to shift outcomes from high mortality and disability toward improved survival and functional independence.ICU Care for Severe Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/icu-care-for-severe-traumatic-brain-injury/31988/Special considerations associated with ICU care of severe TBI, including ABC, intracranial hypertension, and neurologic/systemic complicationsMultiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.AntiCD20+ Agents
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/anticd20-agents/31630/AntiCD20+ agents are among the highest efficacy treatments for multiple sclerosis.The Diagnosis of Functional Movement Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-diagnosis-of-functional-movement-disorder/31884/Functional movement disorder is diagnosed using positive signs, allowing a clinician to “rule-in” the diagnosis.Cluster Headache and Other Trigeminal Autonomic Cephalalgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-and-other-trigeminal-autonomic-cephalalgias/32001/Accurate and timely classification of cluster headache vs other TACs can help speed time to relief and remission in those with headache pain.The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-prognostic-utility-of-neurofilament-light-chain-in-multiple-sclerosis-a-narrative-review/32098/Neurofilament light chain has great promise as a prognostic biomarker in multiple sclerosis.Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.